Evidence map›Paper›PMID 40243547›Full record

ArticleLa Medicina del lavoro2025

Assessment of a Systematic Screening of Occupational Exposures in Malignant Hemopathies in the Rhone-Alpes Area: Prolymphome Study.

Olivia Pérol, Rejane Remion, Barbara Charbotel, Béatrice Fervers

Abstract readMulticenter Study
In one paragraph

Article in La Medicina del lavoro, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. When Occupational Cancer Recognition Falters.La Medicina del lavoro · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Olivia PérolDépartement Prévention Cancer Environnement, Centre Léon Bérard, Lyon, France / INSERM U1296 Radiations : Défense, Santé, Environnement, Centre Léon Bérard, Lyon, France.
Rejane RemionUMRESTTE (Unité Mixte IFSTTAR/UCBL), Université Lyon 1, Lyon, France / Service des Maladies Professionnelles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
Barbara CharbotelUMRESTTE (Unité Mixte IFSTTAR/UCBL), Université Lyon 1, Lyon, France / Service des Maladies Professionnelles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
Béatrice FerversDépartement Prévention Cancer Environnement, Centre Léon Bérard, Lyon, France / INSERM U1296 Radiations : Défense, Santé, Environnement, Centre Léon Bérard, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have highlighted the role of environmental exposures in malignant hemopathies etiology. Some patients with malignant hemopathies can be compensated as occupational diseases. The Prolymphome research aimed to assess a systematic screening of occupational exposures in patients with lymphoma or myeloma treated in three hospitals in the Rhône-Alpes region.

methodsPatients received a self-administered questionnaire to fill in at home to collect their job history and potential occupational exposures to carcinogens. A physician assessed the questionnaire to determine if a dedicated consultation was required and the possibility of claiming compensation. Patients were systematically assisted by a social worker for administrative procedures.

resultsIn 12 months, 754 patients were enrolled in the study, and 361 (48%) returned the questionnaire. A specialized consultation was proposed for 123 patients, and 98 patients attended the consultation. Overall, a compensation claim was proposed to 18 patients: 11 have been occupationally exposed to pesticides and seven to trichloroethylene.

conclusionsOur results confirmed the feasibility of the systematic screening procedure. Barriers were observed at every step of the process, and it underlined that patients are rarely  nformed about occupational exposures. As the prevalence of occupational exposures in malignant hemopathies remains scarce, a systematic targeted screening could be relevant in this population.

Indexed as

LymphomaMass ScreeningMultiple MyelomaOccupational DiseasesOccupational ExposureAdultAgedFeasibility StudiesFemaleHumansItalyMaleMiddle AgedSurveys and Questionnaires

Identifiers

PMID40243547
PMCPMC12120781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.